Clinical Trials

Colorectal Cancer (Colon Cancer and Rectal Cancer)

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 7 of 7 Clinical Trials Related to Colorectal Cancer (Colon Cancer and Rectal Cancer)

Clinical Research Trial

S1820

A Randomized Trial of the Altering Intake, Managing Symptoms Intervention for Bowel Dysfunction in Rectal Cancer Survivors Compared to a Healthy Living Education Control: A Feasibility and Preliminary Efficacy Study

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

NRG-GI005

Phase II/III Study of Circulating tumOr DNA as a Predictive BiomaRker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA)

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

S0820

A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon or Rectal Cancer

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

NRG GI-004

Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or Without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

A021502-ATOMIC: Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair (Atomic: Adjuvant Trial of Deficient Mismatch Repair in Colon Cancer).

A021502-ATOMIC: Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair

Doctor(s) Running This Study
Suresh G. Nair, MD